$JOBY

Joby Aviation Agrees to Buy Resonant Sciences for $500 Million to Expand Defense Business

Joby Aviation agreed to buy Resonant Sciences for $500 million, with consideration in cash and stock, to expand its defense business. Resonant, based in Ohio, makes radio-frequency and sensor systems and will become a separate defense division led by CEO J. Micah North. Resonant reported $100 million revenue over 12 months and works on classified U.S. programs.

Original reporting
Published Aug 11, 2026, 4:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Joby Aviation Agrees to Buy Resonant Sciences for $500 Million to Expand Defense Business — source image
Decision brief

The 30-second read

$JOBYBullishMed
01

Why it matters

Acquiring Resonant Sciences adds radio-frequency and sensor systems plus an existing revenue base and classified government programs, potentially improving defense credibility while Joby continues eVTOL certification and production ramp efforts.

02

Market read

A $500 million cash-and-stock acquisition is a fresh M&A catalyst that can shift valuation expectations for Joby’s defense revenue and technology roadmap.

03

What to watch

Financing terms, regulatory/DoD contracting timelines for classified work, and whether Resonant’s revenue is durable post-acquisition are not detailed here.

Relevance 9/10Novelty 8/10Timing: deal announced today

Background

Joby is developing electric air taxis and has been building defense-related aircraft and autonomy capabilities, including work tied to turbine-electric and hydrogen-electric propulsion concepts.

Company-level read

Ticker impact

$JOBYBullishMedium confidence
Context

Joby Aviation agreed to buy Resonant Sciences for $500 million, expanding its defense business via a new defense division.

Expected impact

Likely positive near-term on M&A expansion narrative, but expect volatility tied to integration and financing assumptions.

Evidence & confidence

The article discloses deal size, structure (cash and stock), and strategic rationale (radio-frequency/sensors plus classified programs), which are typically market-moving for growth-stage aerospace names.

Market effects

Highlights consolidation in eVTOL and defense-adjacent avionics, potentially increasing competitive focus on sensors and RF systems.

Resonant’s Ohio footprint may strengthen regional defense-tech supply chain relevance.

Defense technology demand and classified program access can influence investor perception of US aerospace defense spend durability.

Counterpoint

Stock may discount the deal as dilutive or execution-heavy if the stock component is large and integration distracts from eVTOL certification and scaling.

Key entities

  • Joby Aviation

    Acquirer of Resonant Sciences to expand defense business via a separate defense division.

  • Resonant Sciences

    Ohio-based developer of radio-frequency and sensor systems, with $100 million trailing revenue and classified US government programs.

  • L3Harris Technologies

    Defense contractor referenced for a prior agreement to explore a new class of autonomous hybrid VTOL aircraft.

Related articles

$JOBYMed

Stock Market Today, Aug. 11: Joby Aviation Falls 4% After $500M Defense Acquisition and Stock Sale Plan

Joby Aviation (JOBY) fell about 4% to around $8.43 after announcing a $500 million acquisition of Resonant Sciences and a planned $750 million at-the-market stock sale. The company said the deal combines aircraft and propulsion tech with Resonant’s RF sensing and low-observability systems. Investors are watching funding for certification, manufacturing, and launch.

$JOBYMedAI 9/10

Joby to buy Resonant Sciences, establish defense business in $500 million deal

Joby Aviation agreed to buy Resonant Sciences to form a dedicated defense business in a $500 million deal, with about $450 million in cash and $50 million in Joby common stock, subject to regulatory approval and expected to close in H1 2027. Resonant will keep its name and leadership. Joby also entered an equity distribution agreement to sell up to $750 million of common stock.